MA
SUPN icon

MUFG Americas’s Supernus Pharmaceuticals SUPN Stock Holding History

MUFG Americas’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-146
Closed -$4K – 812
2020
Q4 		$4K Buy
+146
New +$3.14K ﹤0.01% 677
2018
Q4 		– Sell
-406
Closed -$20K – 791
2018
Q3 		$20K Hold
406
– – ﹤0.01% 627
2018
Q2 		$24K Hold
406
– – ﹤0.01% 636
2018
Q1 		$19K Sell
406
-125
-24% -$5.22K ﹤0.01% 669
2017
Q4 		$21K Sell
531
-250
-32% -$9.88K ﹤0.01% 733
2017
Q3 		$31K Buy
781
+19
+2% +$822 ﹤0.01% 650
2017
Q2 		$33K Sell
762
-70
-8% -$2.49K ﹤0.01% 624
2017
Q1 		$26K Sell
832
-478
-36% -$12.8K ﹤0.01% 667
2016
Q4 		$33K Sell
1,310
-592
-31% -$13.2K ﹤0.01% 633
2016
Q3 		$47K Sell
1,902
-269
-12% -$6.09K ﹤0.01% 589
2016
Q2 		$44K Buy
2,171
+287
+15% +$5.09K ﹤0.01% 575
2016
Q1 		$29K Sell
1,884
-636
-25% -$8.3K ﹤0.01% 646
2015
Q4 		$34K Sell
2,520
-849
-25% -$13.1K ﹤0.01% 631
2015
Q3 		$47K Buy
3,369
+20
+0.6% +$372 ﹤0.01% 612
2015
Q2 		$57K Buy
3,349
+509
+18% +$7.25K ﹤0.01% 603
2015
Q1 		$34K Buy
2,840
+580
+26% +$5.48K ﹤0.01% 730
2014
Q4 		$19K Buy
2,260
+890
+65% +$7.48K ﹤0.01% 829
2014
Q3 		$12K Buy
+1,370
New +$12.4K ﹤0.01% 915

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

MUFG Americas's SUPN Position: Q1 2021 in Review

MUFG Americas sold out of Supernus Pharmaceuticals (SUPN) in Q1 2021, closing a stake of 146 shares — an estimated $4K sold.

MUFG Americas first reported a position in SUPN in Q3 2014 and held it in 18 quarters. The position peaked at $57K in Q2 2015. 224 funds tracked by Wall St. Rank hold SUPN as of Q1 2021.

  • MUFG Americas reported no remaining Supernus Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • MUFG Americas sold 146 Supernus Pharmaceuticals shares in Q1 2021, an estimated $4K.
  • MUFG Americas first reported a position in Supernus Pharmaceuticals in Q3 2014 and held it in 18 quarters.
  • MUFG Americas's Supernus Pharmaceuticals position peaked at $57K in Q2 2015.
  • 224 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2021.

Based on MUFG Americas's 13F filing for Q1 2021, filed 30 Apr 2021.